Literature DB >> 11841398

Cellular signalling pathways: new targets in leukaemia therapy.

Farhad Ravandi1, Moshe Talpaz, Hagop Kantarjian, Zeev Estrov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841398     DOI: 10.1046/j.1365-2141.2002.03236.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.

Authors:  Florian M Corvinus; Carina Orth; Richard Moriggl; Svetlana A Tsareva; Stefan Wagner; Edith B Pfitzner; Daniela Baus; Roland Kaufmann; Lukas A Huber; Kurt Zatloukal; Hartmut Beug; Peter Ohlschläger; Alexander Schütz; Karl-Jürgen Halbhuber; Karlheinz Friedrich
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

2.  The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines.

Authors:  M Baśkiewicz-Masiuk; M Masiuk; B Machaliński
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

3.  Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Authors:  Pablo Elías Morande; Mariela Sivina; Angimar Uriepero; Noé Seija; Catalina Berca; Pablo Fresia; Ana Inés Landoni; Javier M Di Noia; Jan A Burger; Pablo Oppezzo
Journal:  Blood       Date:  2019-02-27       Impact factor: 25.476

Review 4.  Targeting acute myeloid leukemia stem cell signaling by natural products.

Authors:  Kodappully Sivaraman Siveen; Shahab Uddin; Ramzi M Mohammad
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

5.  Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

Authors:  Harald Herrmann; Katharina Blatt; Junwei Shi; Karoline V Gleixner; Sabine Cerny-Reiterer; Leonhard Müllauer; Christopher R Vakoc; Wolfgang R Sperr; Hans-Peter Horny; James E Bradner; Johannes Zuber; Peter Valent
Journal:  Oncotarget       Date:  2012-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.